Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Non-LTR Retrotransposons

Non-LTR Retrotransposons

As the name suggests, non-LTR retrotransposons lack the long terminal repeats characteristic of the LTR retrotransposons. Additionally, both LTR and non-LTR retrotransposons use distinct mechanisms of mobilization. Non-LTR retrotransposons are further divided into two classes - Long interspersed nuclear elements (LINEs) and short interspersed nuclear elements (SINEs), both of which occur abundantly in most mammals, including humans. Some of the active non-LTR retrotransposons in humans are L1...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Systemic Lupus Erythematosus: What Every Clinician Needs to Know.

Mayo Clinic proceedings·2026

Same author

Chimeric Antigen Receptor T-Cell Therapy in Autoimmune Disorders: An Expert Panel Opinion From the American Society for Transplantation and Cellular Therapy.

Transplantation and cellular therapy·2026

Same author

A MEF2C transcription factor network regulates proliferation of glomerular endothelial cells in diabetic kidney disease.

Kidney international·2026

Same author

Deep profiling of lupus nephritis kidneys reveals dynamic changes in myeloid cells associated with disease progression.

Annals of the rheumatic diseases·2026

Same author

Shared multicellular injury programs of acute and chronic kidney disease enable mechanistic patient stratification.

medRxiv : the preprint server for health sciences·2026

Same author

Urinary clusterin as a biomarker of human kidney disease progression and response to the endothelin receptor antagonist atrasentan: An exploratory analysis from the SONAR trial.

Nature communications·2026

Same journal

KDIGO Life Cycle of Guideline Development Series Part 6: Bridging the Gap between Guidelines and Clinical Practice: The KDIGO Approach to Global Implementation and Education in Nephrology.

Kidney international·2026

Same journal

KDIGO Life Cycle of Guideline Development Series Part 5: Guideline updates and a living model for the future.

Kidney international·2026

Same journal

Crystal-Storing Histiocytosis Causing Severe AKI.

Kidney international·2026

Same journal

Peritoneal dialysis in a patient with extensive burn scarring.

Kidney international·2026

Same journal

COPA syndrome unmasked by anti-neutrophil cytoplasmic antibody-positive immune-complex nephritis.

Kidney international·2026

Same journal

Monitoring anti-nephrin antibodies in the management of recurrent diffuse podocytopathy.

Kidney international·2026

See all related articles

Search research articles

Related Experiment Video

Updated: Aug 27, 2025

Application of Laser Microdissection to Uncover Regional Transcriptomics in Human Kidney Tissue

Application of Laser Microdissection to Uncover Regional Transcriptomics in Human Kidney Tissue

Published on: June 9, 2020

Lupus nephritis transcriptomics across space and time.

Shaun W Jackson¹, Charles E Alpers²

¹Seattle Children's Research Institute, Seattle, Washington, USA; Department of Pediatrics, University of Washington School of Medicine, Seattle, Washington, USA; Department of Laboratory Medicine and Pathology, University of Washington School of Medicine, Seattle, Washington, USA.

Kidney International

|September 23, 2022

Summary

This summary is machine-generated.

Researchers analyzed kidney biopsies to understand why some lupus nephritis treatments fail. This could lead to better therapies for lupus kidney disease, improving patient outcomes.

More Related Videos

Analyses of Proteinuria, Renal Infiltration of Leukocytes, and Renal Deposition of Proteins in Lupus-prone MRL/lpr Mice

Analyses of Proteinuria, Renal Infiltration of Leukocytes, and Renal Deposition of Proteins in Lupus-prone MRL/lpr Mice

Published on: June 8, 2022

Spatial Profiling of Protein and RNA Expression in Tissue: An Approach to Fine-Tune Virtual Microdissection

Spatial Profiling of Protein and RNA Expression in Tissue: An Approach to Fine-Tune Virtual Microdissection

Published on: July 6, 2022

Related Experiment Videos

Last Updated: Aug 27, 2025

Application of Laser Microdissection to Uncover Regional Transcriptomics in Human Kidney Tissue

Application of Laser Microdissection to Uncover Regional Transcriptomics in Human Kidney Tissue

Published on: June 9, 2020

Analyses of Proteinuria, Renal Infiltration of Leukocytes, and Renal Deposition of Proteins in Lupus-prone MRL/lpr Mice

Analyses of Proteinuria, Renal Infiltration of Leukocytes, and Renal Deposition of Proteins in Lupus-prone MRL/lpr Mice

Published on: June 8, 2022

Spatial Profiling of Protein and RNA Expression in Tissue: An Approach to Fine-Tune Virtual Microdissection

Spatial Profiling of Protein and RNA Expression in Tissue: An Approach to Fine-Tune Virtual Microdissection

Published on: July 6, 2022

Area of Science:

Nephrology
Immunology
Genomics

Background:

Current immunosuppression treatments for lupus nephritis (LN) show limited efficacy.
This leads to poor long-term outcomes for patients with LN.
Understanding LN pathogenesis is crucial for developing targeted therapies.

Purpose of the Study:

To identify molecular pathways that differentiate treatment responders from nonresponders in lupus nephritis.
To analyze transcriptomic data from kidney biopsies to find potential therapeutic targets.

Main Methods:

Transcriptomic analysis was performed on kidney biopsies from lupus nephritis patients.
Biopsies were collected before and after treatment.
Samples were segregated into glomerular and tubulointerstitial compartments.

Main Results:

Distinct molecular pathways were identified between treatment responders and nonresponders.
Specific gene expression patterns may predict treatment response in lupus nephritis.
Glomerular and tubulointerstitial compartments show different molecular signatures.

Conclusions:

Transcriptomic analysis reveals key molecular differences in lupus nephritis treatment response.
Identifying these pathways can guide the development of more effective, targeted therapies for lupus nephritis.
This research provides a foundation for precision medicine approaches in managing lupus nephritis.